Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y015179 | — |
patient did not experience any adverse issues or reactions from the administered vaccine and no other information was able to be provided; TE for GARDASIL 9 that took place on 07/08/2025 as well as 08/20/2025 and was inadvertently administered on 08/21/2025; This spontaneous report was received from a medical assistant and refers to a 17-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-Aug-2025 and on 20-Aug-2025, temperature excursion for Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) took place was inadvertently administered on 21-Aug-2025, when the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), (lot #Y015179, expiration date: 28-Jan-2027) (0.5mL / once) for prophylaxis (improper storage of product in use). The patient did not experience any adverse issues or reactions from the administered vaccine and no other information was able to be provided (no adverse event).